BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • May 18th, 2020 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Boston Scientific Corporation (the “Company”) proposes to issue and sell its Debt Securities having an aggregate principal amount of U.S. $1,700,000,000 or the equivalent thereof in foreign currencies or currency units (the “Securities”). The Securities will be issued under an indenture dated as of May 29, 2013 between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented from time to time by supplemental indentures and/or modified from time to time by resolutions of the Board of Directors of the Company, Pricing Certificate of Authorized Officers thereof or Officer’s Certificate as provided in Section 301 of such indenture (such indenture as so supplemented and/or modified being hereinafter referred to as the “Indenture”).
ContractIndenture • May 18th, 2020 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
This Security is a Registered Security in permanent global form within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depositary or a nominee of the Depositary. This Security is exchangeable for Securities registered in the name of a person other than the Depositary or its nominee only in the limited circumstances described in the Indenture. Unless and until it is exchanged in whole or in part for Securities in definitive registered form, this Security may not be transferred except as a whole by the Depositary to the nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary.
